Research News for September 7, 2022
advertisement
- Oxford scientists launch study into early markers of type 1 diabetes in children
- Guidance for high-dose vitamin D supplementation for prolonging the honeymoon phase in children and adolescents with new-onset type 1 diabetes (Full text HTML, PDF)
- TXNIP inhibition in the treatment of diabetes. Verapamil as a novel therapeutic modality in diabetic patients (Full text HTML, PDF)
- Type 1 Diabetes Mellitus-Related circRNAs Regulate CD4+ T Cell Functions (Full text HTML, PDF)
- Host-microbiota interactions shaping T-cell response and tolerance in type 1 diabetes
- Anti-CD3 monoclonal antibodies for the prevention and treatment of type 1 diabetes: A literature review
- Biology and Natural History of Type 1 Diabetes Mellitus
- Cell therapy for type 1 diabetes: from islet transplantation to stem cells (Full text HTML)
- Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK
- Downregulation of mapk/mak/mrk overlapping kinase 1 in peripheral blood mononuclear cells of pediatric patients with type 1 diabetes mellitus (Full text HTML, PDF)
- The Role of Mesenchymal Stem Cells in the Treatment of Type 1 Diabetes (Full text HTML, PDF)
- Cathepsin D Drives the Formation of Hybrid Insulin Peptides Relevant to the Pathogenesis of Type 1 Diabetes
- A systematic review and Meta-analysis of urinary extracellular vesicles proteome in diabetic nephropathy
- Red blood cells in type 1 diabetes and multiple sclerosis and technologies to measure their emerging roles (Full text HTML, PDF)
